In large multinational clinical therapeutic trials, responses in one region can differ from those in another. This article examines reasons for such differences and suggests criteria for determining whether the differences are real or the play of chance.
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2016) studied this question.